{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:19:11Z","timestamp":1789705151233,"version":"4.0.1"},"reference-count":63,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2002,1,12]],"date-time":"2002-01-12T00:00:00Z","timestamp":1010793600000},"content-version":"vor","delay-in-days":256,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Pathol"],"published-print":{"date-parts":[[2001,5]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Cutaneous lymphocyte\u2010associated antigen (CLA) is a lymphocyte homing receptor selectively expressed by T cells of the cutaneous immune system and their malignant counterpart, that is to say, cutaneous T\u2010cell lymphomas. However it is absent in the vast mayority of other T\u2010cell malignancies and B\u2010cell lineage lymphomas irrespective on primary tumor site.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Expression of CLA was investigated on six cases of mantle cell lymphoma (MCL) which differed in their histopathological subtype (typical or blastic) and their tendency to infiltrate skin and\/or central nervous system (CNS).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> CLA immunostaining on neoplastic cells was only observed in a 61\u2010year\u2010old female suffering from a lymphoblastoid MCL which clinically presented with specific skin lesions and further developped CNS disease. In this patient, coexpression of CLA with MCL markers (CD20 and CD5) was confirmed by conventional immunohistochemistry and double immunofluorescence studies.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> To our knowledge, CLA immunoreactivity on B\u2010cell lymphomas has not beeen previously reported. The expression of this skin\u2010related adhesion molecule on malignant MCL cells could explain the clinical behavior of our case which presented and relapsed with cutaneous lesions. However, CLA seems not to be a MCL marker nor a CNS\u2010related adhesion molecule. The authors review the clinical and histopathological characteristics of MCL\u2010specific skin lesions and their diagnostic clues based on cell morphology, immunohistochemistry and molecular investigations.<\/jats:p>","DOI":"10.1034\/j.1600-0560.2001.028005256.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T13:53:23Z","timestamp":1047390803000},"page":"256-264","source":"Crossref","is-referenced-by-count":28,"title":["Cutaneous lymphocyte\u2010associated antigen (CLA) expression in a lymphoblastoid mantle cell lymphoma presenting with skin lesions. Comparison with other clinicopathologic presentations of mantle cell lymphoma<sup>Note<\/sup>"],"prefix":"10.1034","volume":"28","author":[{"given":"R. M.","family":"Mart\u00ed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Palou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Estrach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,12]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"409","article-title":"Lymphomas of follicles. Mantle cell and follicle center cell lymphomas.","volume":"99","author":"Weisenburger DD","year":"1993","journal-title":"Hematopathology"},{"key":"e_1_2_7_3_2","first-page":"12","article-title":"Mantle cell lymphoma. Accurate diagnosis yeilds clinical insights.","volume":"120","author":"Campo E","year":"1996","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_7_4_2","first-page":"115","article-title":"Mantle cell lymphoma.","volume":"36","author":"Campo E","year":"1999","journal-title":"Semin Hematol"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19871201)60:11<2717::AID-CNCR2820601123>3.0.CO;2-K"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1361.1361"},{"key":"e_1_2_7_7_2","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","article-title":"Mantle cell lymphoma: a clinicopathologic study of 80 cases.","volume":"89","author":"Argatoff LH","year":"1997","journal-title":"Blood"},{"key":"e_1_2_7_8_2","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.5858\/1999-123-1182-MCL","article-title":"Mantle cell lymphoma. Molecular and immunophenotypic diagnostic aids.","volume":"123","author":"Hankin RC","year":"1999","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199008000-00007"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a059154"},{"issue":"2","key":"e_1_2_7_11_2","first-page":"S60","article-title":"Mantle cell lymphoma: diagnostic criteria, clinical aspects and therapeutics problems.","volume":"11","author":"Meusers P","year":"1997","journal-title":"Leukemia"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19980201)82:3<567::aid-cncr20>3.3.co;2-8"},{"key":"e_1_2_7_13_2","first-page":"312","article-title":"Mantle cell lymphoma: a retrospective study on 27 patients. Clinical features and natural history.","volume":"83","author":"Bertini M","year":"1998","journal-title":"Haematologica"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401121"},{"key":"e_1_2_7_15_2","first-page":"941","article-title":"CNS involvement in mantle\u2010cell lymphoma.","volume":"14","author":"Montserrat E","year":"1996","journal-title":"J Clin Pathol"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050491"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30189-X"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70002-8"},{"key":"e_1_2_7_19_2","first-page":"1591","article-title":"Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1\/CCND1) mRNA levels and proliferative activity.","volume":"148","author":"Jares P","year":"1996","journal-title":"Am J Pathol"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/105.5.532"},{"key":"e_1_2_7_21_2","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1182\/blood.V87.10.4302.bloodjournal87104302","article-title":"p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis.","volume":"87","author":"Greiner TC","year":"1996","journal-title":"Blood"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.5421085.x"},{"key":"e_1_2_7_23_2","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1182\/blood.V87.8.3351.bloodjournal8783351","article-title":"P53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas.","volume":"87","author":"Hernandez L","year":"1996","journal-title":"Blood"},{"key":"e_1_2_7_24_2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood.V89.1.272","article-title":"Deletions and loss of expression of p16 INK4a and p21 Wafl genes are associated with aggressive variants of mantle cell lymphomas.","volume":"89","author":"Pinyol M","year":"1997","journal-title":"Blood"},{"key":"e_1_2_7_25_2","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.4049\/jimmunol.145.10.3247","article-title":"Differential expresion of homing\u2010associated adhesion molecules by T\u2010cell subsets in man.","volume":"145","author":"Picker LJ","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_7_26_2","first-page":"1053","article-title":"A unique phenotype of skin\u2010associated lymphocytes in humans. Preferential expression of the HECA\u2010452 epitope by benign and malignant T cells at cutaneous sites.","volume":"136","author":"Picker LJ","year":"1990","journal-title":"Am J Pathol"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1992.tb00343.x"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12364814"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00372006"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.03031.x"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199912093412407"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1993.tb00470.x"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/349796a0"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.174.6.1461"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0952-7915(94)90118-X"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004030050199"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30190-6"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1037\/\/0096-1523.20.5.1000"},{"key":"e_1_2_7_39_2","first-page":"82","article-title":"Reticulohistiocytoma of the dorsum (Crosti's disease) and other B\u2010cell lymphomas.","volume":"2","author":"Berti E","year":"1991","journal-title":"Sem Diagn Pathol"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910501)67:9<2311::AID-CNCR2820670918>3.0.CO;2-0"},{"key":"e_1_2_7_41_2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archderm.1993.01680240093016","article-title":"Skin\u2010associated lymphoid tissue (SALT)\u2010related B\u2010cell lymphoma (primary cutaneous B\u2010cell lymphoma). A concept and a clinicopathologic entity.","volume":"129","author":"Giannotti B","year":"1999","journal-title":"Arch Dermatol"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1996.03890350042008"},{"key":"e_1_2_7_43_2","first-page":"231","article-title":"Utility of immunohistochemistry in the diagnosis of cutaneous lymphoma.","volume":"10","author":"Estrach T","year":"1995","journal-title":"Skin Cancer"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1085-5629(99)80010-8"},{"key":"e_1_2_7_45_2","first-page":"859","article-title":"Usefulness of a new CD5 antibody for the diagnosis of T\u2010cell and B\u2010cell lymphoproliferative disorders in paraffin sections.","volume":"10","author":"Dorfman DM","year":"1997","journal-title":"Mod Pathol"},{"key":"e_1_2_7_46_2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ajcp\/109.6.682","article-title":"Improved detection of CD5 in formalin\u2010fixed paraffin\u2010embedded sections of benign and neoplastic lymphoid tissues by using biotinylated tyramine enhancement after antigen retrieval.","volume":"109","author":"Butmarc JR","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"e_1_2_7_47_2","first-page":"31","article-title":"Detection of CD5 antigen on B cell lymphomas in fixed, paraffin\u2010embedded tissues using signal amplification by catalyzed reporter deposition.","volume":"42","author":"Luo JH","year":"1998","journal-title":"Eur J Histochem"},{"key":"e_1_2_7_48_2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/ajcp\/108.3.302","article-title":"Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low\u2010grade B\u2010cell neoplasms in bone marrow.","volume":"108","author":"Vasef MA","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1999.00662.x"},{"key":"e_1_2_7_50_2","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1182\/blood.V69.6.1617.1617","article-title":"Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings.","volume":"69","author":"Weisenburger DD","year":"1987","journal-title":"Blood"},{"key":"e_1_2_7_51_2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood.V76.7.1387.1387","article-title":"Genotypic characterization of centrocytic lymphoma: frequent rearrrangement of the chromosome 11 bcl\u20101 locus.","volume":"76","author":"Williams ME","year":"1990","journal-title":"Blood"},{"key":"e_1_2_7_52_2","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1182\/blood.V76.10.2086.2086","article-title":"Association of bcl\u20101 rearrangements with lymphocytic lymphoma of intermediate differentiation.","volume":"76","author":"Medeiros LJ","year":"1990","journal-title":"Blood"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711630104"},{"key":"e_1_2_7_54_2","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1182\/blood.V81.11.3063.3063","article-title":"Rearrangement and overexpression of the bcl\u20101\/PRAD\u20101 gene in intermediate lymphocytic lymphomas and in t(11q13)\u2010bearing leukemias.","volume":"81","author":"Rimokh R","year":"1993","journal-title":"Blood"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb04830.x"},{"key":"e_1_2_7_56_2","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood.V84.8.2726.2726","article-title":"PRAD\u20101\/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma.","volume":"84","author":"Bosch F","year":"1994","journal-title":"Blood"},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-9525(00)89074-5"},{"key":"e_1_2_7_58_2","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer.","volume":"90","author":"Willemze R","year":"1997","journal-title":"Blood"},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65684-2"},{"key":"e_1_2_7_60_2","first-page":"147","article-title":"High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA\u2010452.","volume":"130","author":"Duijvestijn AM","year":"1988","journal-title":"Am J Pathol"},{"key":"e_1_2_7_61_2","first-page":"11","article-title":"Dendritic cells and high endothelial venules in the rheumatoid synovial membrane.","volume":"17","author":"Van Dinther\u2010Janssen ACHM","year":"1990","journal-title":"J Rheumatol"},{"key":"e_1_2_7_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12874646"},{"key":"e_1_2_7_63_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00372006"},{"key":"e_1_2_7_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12377706"}],"container-title":["Journal of Cutaneous Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0560.2001.028005256.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0560.2001.028005256.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T21:49:26Z","timestamp":1697492966000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0560.2001.028005256.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["10.1034\/j.1600-0560.2001.028005256.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0560.2001.028005256.x","archive":["Portico"],"relation":{},"ISSN":["0303-6987","1600-0560"],"issn-type":[{"value":"0303-6987","type":"print"},{"value":"1600-0560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}